Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 7, 2012; 18(29): 3775-3781
Published online Aug 7, 2012. doi: 10.3748/wjg.v18.i29.3775
Published online Aug 7, 2012. doi: 10.3748/wjg.v18.i29.3775
ALT or GPT |
Catalyzes the reversible transamination1 between alanine and 2-oxoglutarate to form pyruvate and glutamate: L-alanine + 2-oxoglutarate = pyruvate + L-glutamate |
ALT has both degradative and biosynthetic roles in the glutamate cycling |
ALT participates in cellular nitrogen metabolism and also in liver gluconeogenesis starting with precursors transported from skeletal muscles |
ALT is present in tissues including liver, kidney, heart, and skeletal muscle. |
AST or GOT |
Catalyzes the reversible transamination between L-aspartate and 2-oxoglutarate to form oxaloacetate and glutamate: L-alanine + 2-oxoglutarate |
L-aspartate + 2-oxoglutarate = oxaloacetate + L-glutamate |
Cytosolic AST (GOT 1 catalyzes the reversible reaction of oxaloacetate and glutamate to form aspartate and 2-oxoglutarate (alpha-ketoglutarate) |
AST has two isoforms: cytoplasmatic and mitochondrial |
Symbol | Description | Score |
HNF4A | Hepatocyte nuclear factor 4, alpha [source: HGNC symbol; Acc: 5024] | 66.77 |
IDH2 | Isocitrate dehydrogenase 2 (NADP+), mitochondrial [source: HGNC symbol; Acc: 5383] | 62.04 |
IDH1 | Isocitrate dehydrogenase 1 (NADP+), soluble [source: HGNC symbol; Acc: 5382] | 61.96 |
GPT | Glutamic-pyruvate transaminase (alanine aminotransferase) [source: HGNC symbol; Acc: 4552] | 58.97 |
GOT1 | Glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) [source: HGNC symbol; Acc: 4432] | 54.78 |
GOT2 | Glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) [source: HGNC symbol; Acc: 4433] | 54.48 |
IDH3A | Isocitrate dehydrogenase 3 (NAD+) alpha [source: HGNC symbol; Acc: 5384] | 2.68 |
IDH3G | Isocitrate dehydrogenase 3 (NAD+) gamma [source: HGNC symbol; Acc: 5386] | 2.6 |
IDH3B | Isocitrate dehydrogenase 3 (NAD+) beta [source: HGNC symbol; Acc: 5385] | 2.56 |
ALAS1 | Aminolevulinate, delta-, synthase 1 [source: HGNC symbol; Acc: 396] | 1.57 |
GOT1L1 | Glutamic-oxaloacetic transaminase 1-like 1 [source: HGNC symbol; Acc: 28487] | 1.35 |
ACCSL | 1-aminocyclopropane-1-carboxylate synthase homolog (Arabidopsis)(non-functional)-like [source: HGNC symbol; Acc: 34391] | 1.14 |
GPT2 | Glutamic pyruvate transaminase (alanine aminotransferase) 2 [source: HGNC symbol; Acc: 18062] | 1.03 |
ACCS | 1-aminocyclopropane-1-carboxylate synthase homolog (Arabidopsis)(non-functional) [source: HGNC symbol; Acc: 23989] | 0.98 |
TAT | Tyrosine aminotransferase [source: HGNC symbol; Acc: 11573] | 0.93 |
AADAT | Aminoadipate aminotransferase [source: HGNC symbol; Acc: 17929] | 0.88 |
CCBL1 | Cysteine conjugate-beta lyase, cytoplasmic [source: HGNC symbol; Acc: 1564] | 0.87 |
CCBL2 | Cysteine conjugate-beta lyase 2 [source: HGNC symbol; Acc: 33238] | 0.83 |
SPTLC3 | Serine palmitoyltransferase, long chain base subunit 3 [source: HGNC symbol; Acc: 16253] | 0.82 |
ALAS2 | Aminolevulinate, delta-, synthase 2 [source: HGNC symbol; Acc: 397] | 0.8 |
SPTLC2 | Serine palmitoyltransferase, long chain base subunit 2 [source: HGNC symbol; Acc: 11278] | 0.79 |
SPTLC1 | Serine palmitoyltransferase, long chain base subunit 1 [source: HGNC symbol; Acc: 11277] | 0.75 |
PC | Pyruvate carboxylase [source: HGNC symbol; Acc: 8636] | 0.69 |
SLC2A4 | Solute carrier family 2 (facilitated glucose transporter), member 4 [source: HGNC symbol; Acc: 11009] | 0.69 |
GCAT | Glycine C-acetyltransferase [source: HGNC symbol; Acc: 4188] | 0.66 |
RCAN1 | Regulator of calcineurin 1 [source: HGNC symbol; Acc: 3040] | 0.56 |
SEPSECS | Sep (O-phosphoserine) tRNA: Sec (selenocysteine) tRNA synthase [source: HGNC symbol; Acc: 30605] | 0.56 |
GLUD1 | Glutamate dehydrogenase 1 [source: HGNC symbol; Acc: 4335] | 0.55 |
SHMT2 | Serine hydroxymethyltransferase 2 (mitochondrial) [source: HGNC symbol; Acc: 10852] | 0.54 |
CTH | Cystathionase (cystathionine gamma-lyase) [source: HGNC symbol; Acc: 2501] | 0.52 |
AGXT2L2 | Alanine-glyoxylate aminotransferase 2-like 2 [source: HGNC symbol; Acc: 28249] | 0.49 |
RCAN2 | Regulator of calcineurin 2 [source: HGNC symbol; Acc: 3041] | 0.49 |
AGXT | Alanine-glyoxylate aminotransferase [source: HGNC symbol; Acc: 341] | 0.48 |
GLDC | Glycine dehydrogenase (decarboxylating) [source: HGNC symbol; Acc: 4313] | 0.48 |
GADL1 | Glutamate decarboxylase-like 1 [source: HGNC symbol; Acc: 27949] | 0.47 |
PDXDC1 | Pyridoxal-dependent decarboxylase domain containing 1 [source: HGNC symbol; Acc: 28995] | 0.45 |
AGXT2 | Alanine--glyoxylate aminotransferase 2 [source: HGNC symbol; Acc: 14412] | 0.45 |
GAD2 | Glutamate decarboxylase 2 (pancreatic islets and brain, 65 kDa) [source: HGNC symbol; Acc: 4093] | 0.43 |
SCLY | Selenocysteine lyase [source: HGNC symbol; Acc: 18161] | 0.43 |
AGXT2L1 | Alanine-glyoxylate aminotransferase 2-like 1 [source: HGNC symbol; Acc: 14404] | 0.42 |
ABAT | 4-aminobutyrate aminotransferase [source: HGNC symbol; Acc: 23] | 0.42 |
DDC | Dopa decarboxylase (aromatic L-amino acid decarboxylase) [source: HGNC symbol; Acc: 2719] | 0.42 |
KYNU | Kynureninase [source: HGNC symbol; Acc: 6469] | 0.41 |
OAT | Ornithine aminotransferase [source: HGNC symbol; Acc: 8091] | 0.4 |
SHMT1 | Serine hydroxymethyltransferase 1 (soluble) [source: HGNC symbol; Acc: 10850] | 0.4 |
PSAT1 | Phosphoserine aminotransferase 1 [source: HGNC symbol; Acc: 19129] | 0.39 |
GAD1 | Glutamate decarboxylase 1 (brain, 67 kDa) [source: HGNC symbol; Acc: 4092] | 0.38 |
CSAD | Cysteine sulfinic acid decarboxylase [source: HGNC symbol; Acc: 18966] | 0.38 |
NFS1 | NFS1 nitrogen fixation 1 homolog (S. cerevisiae) [source: HGNC symbol; Acc: 15910] | 0.38 |
ACO1 | Aconitase 1, soluble [source: HGNC symbol; Acc: 117] | 0.37 |
SGPL1 | Sphingosine-1-phosphate lyase 1 [source: HGNC symbol; Acc: 10817] | 0.36 |
HDC | Histidine decarboxylase [source: HGNC symbol; Acc: 4855] | 0.36 |
MOCOS | Molybdenum cofactor sulfurase [source: HGNC symbol; Acc: 18234] | 0.31 |
ZNHIT3 | Zinc finger, HIT-type containing 3 [source: HGNC symbol; Acc: 12309] | 0.3 |
COQ9 | Coenzyme Q9 homolog (S. cerevisiae) [source: HGNC symbol; Acc: 25302] | 0.3 |
ESRRA | Estrogen-related receptor alpha [source: HGNC symbol; Acc: 3471] | 0.3 |
Gene ontology annotation | Q value | Genes in network | Genes in genome |
Transaminase activity | 4.86E-31 | 14 | 16 |
Transferase activity, transferring nitrogenous groups | 6.17E-30 | 14 | 18 |
Mitochondrial matrix | 3.10E-15 | 16 | 220 |
Cellular amino acid catabolic process | 7.40E-15 | 12 | 77 |
Amine catabolic process | 1.13E-14 | 12 | 81 |
Dicarboxylic acid metabolic process | 1.75E-14 | 9 | 24 |
Cellular amino acid biosynthetic process | 5.90E-13 | 10 | 54 |
Carboxylic acid catabolic process | 2.55E-12 | 12 | 131 |
2-oxoglutarate metabolic process | 2.55E-12 | 7 | 13 |
Organic acid catabolic process | 2.55E-12 | 12 | 131 |
Amine biosynthetic process | 8.11E-12 | 10 | 72 |
Glutamate metabolic process | 1.08E-10 | 6 | 10 |
Carboxylic acid biosynthetic process | 4.53E-10 | 11 | 154 |
Organic acid biosynthetic process | 4.53E-10 | 11 | 154 |
Small molecule catabolic process | 4.87E-10 | 12 | 211 |
Small molecule biosynthetic process | 2.21E-9 | 12 | 241 |
Cofactor metabolic process | 2.24E-8 | 10 | 163 |
Vitamin B6 binding | 9.53E-8 | 5 | 12 |
Glutamine family amino acid metabolic process | 9.53E-8 | 6 | 27 |
Cellular aromatic compound metabolic process | 9.53E-8 | 9 | 135 |
Pyridoxal phosphate binding | 9.53E-8 | 5 | 12 |
Cofactor binding | 6.48E-7 | 7 | 69 |
Aromatic amino acid family catabolic process | 1.24E-6 | 5 | 19 |
Coenzyme metabolic process | 1.46E-6 | 8 | 126 |
Aromatic compound catabolic process | 3.14E-6 | 5 | 23 |
Aromatic amino acid family metabolic process | 3.14E-6 | 5 | 23 |
Vitamin binding | 8.74E-6 | 5 | 28 |
Indolalkylamine catabolic process | 1.08E-5 | 4 | 11 |
Indole-containing compound catabolic process | 1.08E-5 | 4 | 11 |
Tryptophan catabolic process | 1.08E-5 | 4 | 11 |
Tryptophan metabolic process | 1.48E-5 | 4 | 12 |
Indolalkylamine metabolic process | 1.48E-5 | 4 | 12 |
Indole-containing compound metabolic process | 1.48E-5 | 4 | 12 |
Cellular biogenic amine catabolic process | 3.93E-5 | 4 | 15 |
Serine family amino acid metabolic process | 5.07E-5 | 4 | 16 |
Acetyl-CoA catabolic process | 1.23E-4 | 4 | 20 |
Tricarboxylic acid cycle | 1.23E-4 | 4 | 20 |
Coenzyme catabolic process | 1.23E-4 | 4 | 20 |
Cofactor catabolic process | 3.67E-4 | 4 | 26 |
Aerobic respiration | 4.88E-4 | 4 | 28 |
Cellular biogenic amine metabolic process | 6.98E-4 | 5 | 71 |
Lyase activity | 8.37E-4 | 5 | 74 |
Acetyl-CoA metabolic process | 1.01E-3 | 4 | 34 |
Transferase activity, transferring acyl groups other than amino-acyl groups | 1.41E-3 | 5 | 83 |
Gluconeogenesis | 3.05E-3 | 4 | 45 |
Aspartate family amino acid catabolic process | 3.67E-3 | 3 | 15 |
Generation of a signal involved in cell-cell signaling | 3.67E-3 | 6 | 178 |
Signal release | 3.67E-3 | 6 | 178 |
Transferase activity, transferring acyl groups | 3.67E-3 | 5 | 103 |
Sulfur amino acid metabolic process | 4.26E-3 | 3 | 16 |
Neurotransmitter secretion | 5.20E-3 | 4 | 53 |
Hexose biosynthetic process | 5.50E-3 | 4 | 54 |
Water-soluble vitamin metabolic process | 6.24E-3 | 4 | 56 |
Monosaccharide biosynthetic process | 1.04E-2 | 4 | 64 |
Pteridine-containing compound metabolic process | 1.05E-2 | 3 | 22 |
Neurotransmitter transport | 1.14E-2 | 4 | 66 |
Carbon-carbon lyase activity | 1.48E-2 | 3 | 25 |
Aspartate family amino acid metabolic process | 1.48E-2 | 3 | 25 |
Regulation of neurotransmitter levels | 1.60E-2 | 4 | 73 |
Sphingolipid metabolic process | 1.82E-2 | 4 | 76 |
Alcohol biosynthetic process | 1.82E-2 | 4 | 76 |
Pigment biosynthetic process | 1.96E-2 | 3 | 28 |
Membrane lipid metabolic process | 2.35E-2 | 4 | 82 |
Sphingolipid biosynthetic process | 2.35E-2 | 3 | 30 |
Cofactor biosynthetic process | 2.53E-2 | 4 | 84 |
Membrane lipid biosynthetic process | 2.77E-2 | 3 | 32 |
Cellular modified amino acid metabolic process | 2.81E-2 | 4 | 87 |
Cellular carbohydrate biosynthetic process | 4.06E-2 | 4 | 96 |
Pigment metabolic process | 4.80E-2 | 3 | 39 |
Vitamin metabolic process | 4.80E-2 | 4 | 101 |
- Citation: Sookoian S, Pirola CJ. Alanine and aspartate aminotransferase and glutamine-cycling pathway: Their roles in pathogenesis of metabolic syndrome. World J Gastroenterol 2012; 18(29): 3775-3781
- URL: https://www.wjgnet.com/1007-9327/full/v18/i29/3775.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i29.3775